CNSY earnings / call / takeaways
CNSY Q3 FY26 earnings call: key takeaways
What CNSY said on its earnings call of November 16, 2026: results against expectations, what changed since last quarter, guidance and the questions analysts pressed on.
By Lician·November 16, 2026·AI-generated from the call transcript and Lician data
- CNSY reported $0.7 million in net diagnostic revenue for Q3 2026, with gross billings of $1.55 million, and reaffirmed its guidance for an annualized gross billing run rate of $10 million to $12.5 million by year-end (30:09)
What changed since last quarter
- The company reaffirmed its guidance for an annualized gross billing run rate of $10 million to $12.5 million by year-end. (32:09)
- CNSY expects to secure Medicare reimbursement in the first half of 2027, which is consistent with previous expectations. (25:57)
- The sales team expansion is underway, with plans to start with four salespeople and grow throughout the year. (43:14)
What analysts pressed on
In their words
Read the full transcript with the AI summary, or listen on the company's official webcast.
Every past call in full and transcript search come with Lician Pro.
Written by AI from the automatic transcript of the company's public webcast and Lician's earnings data. Each sentence cites the passage it comes from, and a sentence with a figure that is not in its sources was removed. Not investment advice.